Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence?

Clinical Infectious Diseases

Volumn 48, Issue 6, 2009, Pages 822-826

  Braithwaite, R Scott ^a,b,k   Roberts, Mark S ^c,d   Goetz, Matthew Bidwell ^e,f   Gibert, Cynthia L ^g,h   Rodriguez Barradas, Maria C ^i,j   Nucifora, Kimberly ^a,b   Justice, Amy C ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Department of Medicine   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^g GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^k 11ACSLG ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPUTER SIMULATION; DISEASE COURSE; EARLY INTERVENTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; THERAPY DELAY; THERAPY EFFECT; TREATMENT REFUSAL; MIDDLE AGED; PATIENT COMPLIANCE; TIME; TREATMENT OUTCOME;

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL AGENTS; COMPUTER SIMULATION; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; MEDICATION ADHERENCE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 62449114931     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/596768     Document Type: Article

References (12)

1. Braithwaite RS, McGinnis K, Conigliaro I, et al. A temporal and doseresponse association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res 2005; 29:1190-7.
2. Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 2003;114:573-80.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
4. Guidelines for the use of antiretroviral agents in HIV - 1-infected adults and adolescents. lanuary 29, 2008. The Panel on Clinical Practices for the Treatment of HIV Infection convened by the Department of Health and Human Services. Available at http://AIDSinfo.nih.gov. Accessed 20 May 2008.
5. Braithwaite RS, Roberts MS, Chang CH, et al. Influence of alternative thresholds for initiating HIV treatment on life expectancy and quality-adjusted life expectancy: a decision model. Ann Intern Med 2008; 148:178-85.
6. Braithwaite RS, Justice AC, Fusco IS, et al. Estimating the proportion of patients infected with human immunodeficiency virus who will die of comorbid disease. Am I Med 2005; 118:890-8.
7. Braithwaite RS, Shechter S, Roberts MS, et al. Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation. I Antimicrob Chemother 2006;58:1036-43.
8. Braithwaite RS, Chang CC, Shechter S, Schaefer A, Roberts MS. Estimating the rate of accumulating drug mutations in the HIV genome. Value in Health 2007; 10:204-13.
9. Hirsch MS, Brun-Vezinet F, D'Aquila RT, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. IAMA 2000;283:2417-26.
10. Gray RH, Wawer MI, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-53.
11. Quinn TC, Wawer MI, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000;342:921-9.
12. Braithwaite RS, Kozal MI, Chang CH, et al. Adherence, virologic and immunologic outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS 2007;21:1579-90.